These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27283127)

  • 61. Impact of Vitamin D Supplementation on Attention-Deficit Hyperactivity Disorder in Children.
    Elshorbagy HH; Barseem NF; Abdelghani WE; Suliman HAI; Al-Shokary AH; Abdulsamea SE; Elsadek AE; Abdel Maksoud YH; Nour El Din DMAE
    Ann Pharmacother; 2018 Jul; 52(7):623-631. PubMed ID: 29457493
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing.
    Wei JL; Mayo MS; Smith HJ; Reese M; Weatherly RA
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):974-9. PubMed ID: 17938319
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationships between behavioral symptoms of non-medicated Chinese children with attention deficit hyperactivity disorder and parenting stress: Comparison of different subtypes and comorbidities.
    Li Y; Jiang WQ; Du YS; Coghill D
    Asia Pac Psychiatry; 2016 Jun; 8(2):127-35. PubMed ID: 26403485
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factorial validity of the Conners' Parent Rating Scale-revised: short form with psychiatric outpatients.
    Kumar G; Steer RA
    J Pers Assess; 2003 Jun; 80(3):252-9. PubMed ID: 12763699
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence supporting the role of telomerase, MMP-9, and SIRT1 in attention-deficit/hyperactivity disorder (ADHD).
    Uzun Cicek A; Mercan Isik C; Bakir S; Ulger D; Sari SA; Bakir D; Cam S
    J Neural Transm (Vienna); 2020 Oct; 127(10):1409-1418. PubMed ID: 32691156
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder.
    Özyurt G; Öztürk Y; Appak YÇ; Arslan FD; Baran M; Karakoyun İ; Tufan AE; Pekcanlar AA
    Compr Psychiatry; 2018 Nov; 87():138-142. PubMed ID: 30414552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder.
    Aydoğan Avşar P; Işık Ü; Aktepe E; Kılıç F; Doğuç DK; Büyükbayram Hİ
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):49-55. PubMed ID: 32757874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ferritin and hyperactivity ratings in attention deficit hyperactivity disorder.
    Oner P; Oner O; Azik FM; Cop E; Munir KM
    Pediatr Int; 2012 Oct; 54(5):688-92. PubMed ID: 22591427
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder.
    Baykal S; Albayrak Y; Durankuş F; Güzel S; Abbak Ö; Potas N; Beyazyüz M; Karabekiroğlu K; Donma MM
    Neurol Sci; 2019 Mar; 40(3):593-602. PubMed ID: 30617449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder.
    Salehi B; Mohammadbeigi A; Sheykholeslam H; Moshiri E; Dorreh F
    J Res Pharm Pract; 2016; 5(1):22-6. PubMed ID: 26985432
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Iron deficiency in Indian children with attention deficit hyperactivity disorder.
    Juneja M; Jain R; Singh V; Mallika V
    Indian Pediatr; 2010 Nov; 47(11):955-8. PubMed ID: 20453262
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanisms involved in dual vasopressin/apelin neuron dysfunction during aging.
    Sauvant J; Delpech JC; Palin K; De Mota N; Dudit J; Aubert A; Orcel H; Roux P; Layé S; Moos F; Llorens-Cortes C; Nadjar A
    PLoS One; 2014; 9(2):e87421. PubMed ID: 24505289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The probable role of adrenomedullin and nitric oxide in childhood attention deficit hyperactivity disorder.
    Gürbüz Özgür B; Aksu H; Yılmaz M; Karakoç Demirkaya S
    Nord J Psychiatry; 2017 Oct; 71(7):521-524. PubMed ID: 28670953
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
    Sahin N; Altun H; Kurutaş EB; Fındıklı E
    Bosn J Basic Med Sci; 2018 May; 18(2):126-131. PubMed ID: 29659348
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder.
    Buyuktaskin D; Guney E; Gulbahar O; Ozaslan A; Arslan B
    Int J Neurosci; 2024 Apr; 134(4):313-317. PubMed ID: 35815398
    [No Abstract]   [Full Text] [Related]  

  • 79. Serum Levels of Interleukin-6 and Tumor Necrosis Factor Alpha in Children With Attention-Deficit Hyperactivity Disorder.
    Elsadek AE; Al-Shokary AH; Abdelghani WE; Kamal NM; Ibrahim AO; El-Shorbagy HH; Suliman HA; Barseem NF; Abdel Maksoud YH; Azab SM; Nour El Din DM
    J Pediatr Neurosci; 2020; 15(4):402-408. PubMed ID: 33936305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum Heat Shock Protein 70 Level in Children with Attention Deficiency Hyperactivity Disorder.
    Özaslan A; Güney E; Gülbahar Ö; Büyüktaşkin Tunçtürk D; Arslan B; Güveli Bozkurt GM
    Noro Psikiyatr Ars; 2022; 59(1):63-67. PubMed ID: 35317506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.